Type I IFN signaling in the absence of IRGM1 promotes M. tuberculosis replication in immune cells by suppressing T cell responses
Open Access
- 20 July 2024
- journal article
- research article
- Published by Elsevier in Mucosal Immunology
- Vol. 17 (5) , 1114-1127
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- Burroughs Wellcome Fund
This publication has 89 references indexed in Scilit:
- Early cellular mechanisms of type I interferon-driven susceptibility to tuberculosisCell, 2023
- Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 PatientsThe Journal of Allergy and Clinical Immunology: In Practice, 2021
- STING Gain-of-Function Disrupts Lymph Node Organogenesis and Innate Lymphoid Cell Development in MiceCell Reports, 2020
- STING-associated lung disease in mice relies on T cells but not type I interferonJournal of Allergy and Clinical Immunology, 2019
- Alveolar Macrophages Provide an Early Mycobacterium tuberculosis Niche and Initiate DisseminationCell Host & Microbe, 2018
- The impact of ISGylation during Mycobacterium tuberculosis infection in miceMicrobes and Infection, 2017
- Type I Interferons Link Viral Infection to Enhanced Epithelial Turnover and RepairCell Host & Microbe, 2015
- Defining features of protective CD4 T cell responses to Mycobacterium tuberculosisCurrent Opinion in Immunology, 2014
- Cell-to-Cell Transfer of M. tuberculosis Antigens Optimizes CD4 T Cell PrimingCell Host & Microbe, 2014
- Type I IFN signaling triggers immunopathology in tuberculosis‐susceptible mice by modulating lung phagocyte dynamicsEuropean Journal of Immunology, 2014